Connect with us

Diseases & Disorders

Women Who Breastfeed Exclusively May Not Experience Multiple Sclerosis Again

Breastfeeding after delivery inhibits multiple sclerosis from relapsing

Published

on

multiple sclerosis - breastfeed pregnant woman
Women with MS may not experience a relapse after pregnancy. Photo Credit: Greyerbaby/Pixabay
Press Release

Researchers just published a valuable information. Women suffering from multiple sclerosis (MP) may not always experience it again after pregnancy. This new discovery contradicts earlier held beliefs about MP. Decades-old belief held that multiple sclerosis may flare up again immediately following pregnancy.

Most people with a history of multiple sclerosis experience the symptoms again when its relapsing-remitting form surfaces, before it remits again. The new finding revealed that women who breastfeed newborns exclusively for several months have lower risks of having multiple sclerosis again.

The conclusions of the study will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia on May 4-10, 2019.

Idea That Multiple Sclerosis Relapses After Pregnancy Dated Back To Decades Ago

MS is usually commong among women who could still bear children. The new discovery however shows that women with the disease can concieve, breastfeed and take up necessary treatments without fearing for relapses after pregnancy.

Annette Langer-Gould, of Kaiser Permanente Southern California and a member of the American Academy of Neurology, said people feared for a relapse of MS after pregnancy since 20+ years ago. This was when MRI scans and innovative treatments were not available to diagnose and treat the condition.

But medical advancements have shown this fear to be baseless.

Langer-Gould and her team analyzed available records from Kaiser Permanente Southern and Northern California databases to arrive at their findings. From the databases, they found that 375 women with MS got pregnant 466 times from 2008 to 2016. Their medical records revealed pertinent information related to MS from their treatment, breastfeeding and relapsing documentations.

Researchers Analyzed Statistics of Multiple Sclerosis Patients from Various Databases

Research showed that 38% of the women were not treated for MS one year before getting pregnant. About 15% experienced the first MS symptoms immediately they got pregnant. And 8% had a relapse while pregnant.

Just a year after delivering their babies, there was crucial development. About 26% of the women suffered MS relapse; 87% of them gave suck to their babies; 35% provided their infants with exclusive breastfeeding; and 41% resumed treatments for the multiple sclerosis.

Data analysis revealed that the yearly rate of relapse for the women before they got pregnant was 0.39. The rate dropped during pregnancy to 0.07 and then 0.14. None of these women experienced any MS relapse immediately following the birth of their baby, and those who eventually did within the first three months of delivery had the rate at 0.27 – lower than what it was before their pregnancy.

However, 4-6 after baby delivery, the annual rate reverted to 0.30, the level it was before pregnancy. The results remained the same even after all necessary factors were accounted for.

Breastfeeding and Resumption of Treatment Does Not Affect Risks of MS Relapse

Ultimately, the researchers found women with MS who exclusively breastfeed their babies have 40% lesser chances of having a relapse. Those who breastfed and also supplemented with milk formula may have a relapse comparable to those who did not breastfeed at all. Funny enough, breastfeeding and taking up MS treatment does not seem to impact the chances of a relapse in any significant way.

For these women, the drugs interferon-betas and glatiramer acetate were mostly used for their treatments. A few others were treated with natalizumab or fingolimod prior to pregnancy. Future studies may address how quitting medications may impact on chances of getting pregnant; effects on breastfeeding; and incidents of relapses during pregnancy.

The study was supported by the National Multiple Sclerosis Society.

This post was originally published on Health News Office

Veronica Owens graduated from MIT in 2013. She worked in Silicon Valley for three years before finding her feet in Journalism. She covers emerging tech trends as they relate to the health industry. She authored a book on the intersection between modern technology and health in 2016. She loves to sew and watch the Super Bowl.

Diseases & Disorders

Corneal Graft Rejection Drug Market Distributors Analysis 2019-2025

Published

on

Press Release

The Corneal Graft Rejection Drug market research encompasses an exhaustive analysis of the market outlook, framework, and socio-economic impacts. The report covers the accurate investigation of the market size, share, product footprint, revenue, and progress rate. Driven by primary and secondary researches, the Corneal Graft Rejection Drug market study offers reliable and authentic projections regarding the technical jargon.

All the players running in the global Corneal Graft Rejection Drug market are elaborated thoroughly in the Corneal Graft Rejection Drug market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Corneal Graft Rejection Drug market players.

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2535870&source=atm

 

Ken-Success
Sitan
ASIT
SPT
Wkdzs
Landau
Ericco
RRK Technology

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Dynamic Tuning Gyroscope Inclinometer
Fibre Optic Gyroscopes Inclinometer
Mechanical Frame Gyroscope Inclinometer
Others

Segment by Application
Geological Survey
Aerospace
Other

Make An Enquiry About This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2535870&source=atm 

Objectives of the Corneal Graft Rejection Drug Market Study:

  • To define, describe, and analyze the global Corneal Graft Rejection Drug market based on oil type, product type, ship type, and region
  • To forecast and analyze the Corneal Graft Rejection Drug market size (in terms of value and volume) and submarkets in 5 regions, namely, APAC, Europe, North America, Central & South America, and the Middle East & Africa
  • To forecast and analyze the Corneal Graft Rejection Drug market at country-level for each region
  • To strategically analyze each submarket with respect to individual growth trends and their contribution to the global Corneal Graft Rejection Drug market
  • To analyze opportunities in the market for stakeholders by identifying high growth segments of the global Corneal Graft Rejection Drug market
  • To identify trends and factors driving or inhibiting the growth of the market and submarkets
  • To analyze competitive developments, such as expansions and new product launches, in the global Corneal Graft Rejection Drug market
  • To strategically profile key market players and comprehensively analyze their growth strategies

The Corneal Graft Rejection Drug market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the Corneal Graft Rejection Drug market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porter’s Five Forces analyses. In addition, the Corneal Graft Rejection Drug market study provides reliable and authentic projections regarding the technical jargon.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2535870&licType=S&source=atm 

After reading the Corneal Graft Rejection Drug market report, readers can:

  • Identify the factors affecting the Corneal Graft Rejection Drug market growth – drivers, restraints, opportunities and trends.
  • Examine the Y-o-Y growth of the global Corneal Graft Rejection Drug market.
  • Analyze trends impacting the demand prospect for the Corneal Graft Rejection Drug in various regions.
  • Recognize different tactics leveraged by players of the global Corneal Graft Rejection Drug market.
  • Identify the Corneal Graft Rejection Drug market impact on various industries. 

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Releases New Report on the Solifenacin Succinate Market

Published

on

Press Release

The ‘Solifenacin Succinate Market’ research report added by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.

The Solifenacin Succinate market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Solifenacin Succinate market and the trends that will prevail in this industry.

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2531619&source=atm

What pointers are covered in the Solifenacin Succinate market research study?

The Solifenacin Succinate market report – Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Solifenacin Succinate market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Solifenacin Succinate market report – Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

Strata Skin Sciences
Verisante
MedX Health
Abbott Laboratory
Medtronic
Siemens AG
Baxter International Inc.
Agilent Technology
Roche
AstraZeneca

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Superficial Spreading Melanoma
Nodular Melanoma
Lentigo Maligna
Acral Lentiginous Melanoma

Segment by Application
Hospital
Clinic
Research Institute
Others

Make An Enquiry About This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2531619&source=atm 

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Solifenacin Succinate market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Solifenacin Succinate market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The ‘Solifenacin Succinate market’ report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2531619&licType=S&source=atm 

Some of the Major Highlights of TOC covers:

  • Development Trend of Analysis of Solifenacin Succinate Market
  • Global Solifenacin Succinate Market Trend Analysis
  • Global Solifenacin Succinate Market Size (Volume and Value) Forecast 2019-2025
  • Marketing Channel
  • Direct Marketing
  • Indirect Marketing
  • Solifenacin Succinate Customers
  • Market Dynamics
  • Market Trends
  • Opportunities
  • Market Drivers
  • Challenges
  • Influence Factors
  • Methodology/Research Approach
  • Research Programs/Design
  • Market Size Estimation
  • Market Breakdown and Data Triangulation
  • Data Source

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Estrogen Replacement Therapy (ERT) Market Research Study for the Period 2016 – 2024

Published

on

Press Release

The Estrogen Replacement Therapy (ERT) market intelligence report from TMR is a valuable tool that enables vendors to identify growth avenues, and strategize for launch of products and services. These findings help businesses pave way in a crowded business landscape, and make way into the future with confidence. The Estrogen Replacement Therapy (ERT) market report depicts the current & future growth trends of this business and outlines geographies that are a part of the regional landscape of the market. 

The analysis and research team at TMR enables customization of Estrogen Replacement Therapy (ERT) market report for any market study. Our experienced research analysts will understand your exact business requirement and provide the most pertinent report for competitive gains.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13460&source=atm

The Estrogen Replacement Therapy (ERT) market report analyzes the historical data from 2014-2019 as well as the present performance of the market and forecast 2019-2024 to make predictions on the future status of the market on the basis of analysis. The report further illuminates details regarding the supply and demand analysis, market share, growth statistics and contributions by leading industry players. While citing a brief analysis of the Estrogen Replacement Therapy (ERT) market, this study report has presented the current scenario of this business space along with a specialized concentration on the industry.

About The Estrogen Replacement Therapy (ERT) Market:

The market research report on Estrogen Replacement Therapy (ERT) also offers valuable insights into key business strategies employed by established players, along with impact of these strategies on future business landscape.

The intelligent research study contains numerical data related to services and products. In addition, the report presents a detailed outline of the marketplace and alongside the numerous developments prevailing across the industry. The Estrogen Replacement Therapy (ERT) market can be divided based on product types and their sub-type, key applications, and major regions. The research study will give the answer to questions about the present performance of the Estrogen Replacement Therapy (ERT) market and the competitive scope, opportunity, challenges, cost and more.

market segment. Rising population, increasing disposable income, and improving health care awareness levels are some the key factors driving the Asia Pacific ERT market. 

Some of the key players operating in the ERT market include AbbVie, Inc., Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma AB, Pfizer, Inc., Meda pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

The study is a source of reliable data on:

  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs 

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, North Africa) 

TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market. 

TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place.  All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=13460&source=atm

The regional analysis covers in the Estrogen Replacement Therapy (ERT) Market Report: 

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa) 

Key Questions Answered in the Estrogen Replacement Therapy (ERT) Market Report 

  1. How much will be overall revenue generation in the Estrogen Replacement Therapy (ERT) market by the end of the forecast period?
  2. Which product segment is likely to gather maximum share by the end of the forecast period?
  3. Which region is likely to hold maximum revenue share by the end of the forecast period?
  4. What are winning strategies adopted by key stakeholders in the Estrogen Replacement Therapy (ERT) market to consolidate their position?
  5. What are key developments witnessed in the Estrogen Replacement Therapy (ERT) market? 

Request TOC For This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=13460&source=atm

Moreover, the research study clarifies the estimates of the market chain with respect to substantial parameters like the Estrogen Replacement Therapy (ERT) market chain structure alongside details related to the downstream industry. The report contains a detailed synopsis of this business space in accordance with the macroeconomic environment analysis as well as macroeconomic environment development trends globally.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

This post was originally published on Health News Office

Continue Reading

Trending